Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection

Immunology

Volumn 98, Issue 1, 1999, Pages 90-97

  Wang, M J ^a   Jeng, K C G ^a   Ping, L I ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; IMMUNE RESPONSE; KLEBSIELLA; LIVER ABSCESS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

EID: 0032834355     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00838.x     Document Type: Article

References (30)

1. 1. HALEY R.W., SCHABERG D.R., CROSSLEY K.B., VON-ALLMEN S.D. & MAGOWAN J.E. JR (1981) Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 70, 51.
2. 2. CENTERS FOR DISEASE CONTROL (1990) Increase in National hospital discharge survey rates for septicemia-United States, 1979. MMWR 39, 31.
3. 3. LIU Y.C., CHENG D.L. & LIN C.L. (1986) Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 146, 1913.
4. 4. WANG L.S., LEE F.Y., CHENG D.L., LIU C.Y., HINTHORN D.R. & JOST P.M. (1990) Klebsiella pneumoniae bacteremia: analysis of 100 episodes. J Formosan Med Asso 89, 756.
5. 5. ZANETTI G., HEUMANN D., GERAIN J. et al. (1992) Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice. J Immunol 148, 1890.
6. 6. TRACEY K.J., FONG Y., HESSE D.G. et al. (1987) Anti-cachetein/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662.
7. 7. CASEY L.C., BALK R.A. & BONE R.C. (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119, 771.
8. 8. SHALABY M.R., AGGARWAL B.B., RINDERKNECHT E., SVERDERSKY L.P., FINKLE B.S. & PALLADINO M.A. (1985) Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 135, 2069.
9. 9. BERMUDEZ L.E.M. & YOUNG L.S. (1988) Tumor necrosis factor alone or in combination with IL-2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140, 3006.
10. 10. CROSS A.S., SADOFF J.C., KELLY N., BERNTON E. & GEMSKI P. (1989) Preteatment with recombinant murine tumor necrosis factor-α/cachectin and murines interleukin 1 α protects mice from lethal bacterial infection. J Exp Med 169, 2021.
11. 11. SILVA A.T., BAYSTON K.F. & COHEN J. (1990) Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor α in experimental Gram-negative shock. J Inf Dis 162, 421.
12. 12. OHLSSON K., BJORK P., BERGENFELDT M., HAGEMAN R. & THOMPSON R.C. (1990) Interleukin 1 receptor antagonist reduced mortality from endotoxin shock. Nature 348, 550.
13. 13. VOGEL S.N. (1992) The LPS gene. Insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation. In: Tumor Necrosis Factor: the Molecules and Their Emerging Role in Medicine (Ed. B. BEUTLER), p. 485. Raven Press, New York.
14. 14. WEINSTEIN D.L., LISSNER C.R., SWANSON R.N. & O'BRIEN A.D. (1986) Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HcJ mice. Cell Immunol 102, 68.
15. 15. SHINJI H., AKAGAWA K.S. & YOSHIDA T. (1994) LPS induces selective translocation of protein kinase C-β in LPS-responsive mouse macrophages, but not in LPS-nonresponsive mouse macrophages. J Immunol 153, 5760.
16. 16. HAGBERG L., BRILES D.E. & EDEN C.S. (1985) Evidence for separate genetic defects in C3H/HcJ and C3HeB/FcJ mice, that affect susceptibility to gram-negative infections. J Immunol 134, 4118.
17. 17. EVANS T., STRIVENS J.E., CARPENTER A. & COHEN J. (1993) Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous Gram-negative infection. J Immunol 150, 5033.
18. 18. DE WAAL M.R., ABRAMS J., BENNETT B., FIGDOR C.G. & DE VRIES J.E. (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209.
19. 19. FIORENTINO D.F., ZLOTNIK A., MOSMANN T.R., HOWARD M. & O'GARRA A. (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147, 3815.
20. 20. STANDIFORD T.J., STRIETER R.M., LUKACS N.W. & KUNKEL S.T. (1995) Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155, 2222.
21. 21. BERMUDEZ L.E. & CHAMPSI J. (1993) Infection with Mycobacterium avium induced production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 61, 3093.
22. 22. ROMANI L., PUCCETTI P., MENCACCI A. et al. (1994) Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 152, 3514.
23. 23. GREENBERGER M.J., STRIETER R.M., KUNKEL S.T., DANFORTH J.M., GOODMAN R.E. & STANFORD T.J. (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155, 722.
24. 24. HOWARD M., O'GARRA A., ISHIDA H., MALEFYT R.D. & DE VRIES J. (1992) Biological properties of interleukin 10. J Clin Immunol 12, 239.
25. 25. ROMAGNANI S. (1994) Lymphokine production by human T cells in disease state. In: Annual Review of Immunology (Eds W.F., PAUL C.G. FATHMAN & H. METZGER), Vol 12, p. 227. Annual Review Inc., Palo Alto, CA.
26. 26. LAICHALK L.L., KUNKEL S.L., STRIETER R.M.M., DANFORTH J.M., BAILIE M.B. & STANDFORD T.J. (1996) Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 64, 5211.
27. 27. TAKASHIMA K., TATEDA K., MATSUMOTO T., ITZAWA Y., NAKAO M. & YAMAGUCHI K. (1997) Role of tumor necrosis factor in pathogeneis of pneumococcal pneumonia in mice. Infect Immun 65, 257.
28. 28. FERRANTE A., MARTIN A.J., BATES E.J. et al. (1993) Killing of Staphylocaccus aureus by tumor necrosis factor-α activated neutrophils. J Immunol 151, 4821.
29. 29. CZUPRYNSKI C.J. & BROWN J.F. (1987) Recombinant murine interleukin-1α enhancement of nonspecific antibacterial resistance. Infect Immun 55, 2061.
30. 30. VAN DER POLL T., MARCHANT A., KEOGH C.V., GOLDMAN M. & LOWRY S. (1996) Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174, 994.